| Serial Number | 79420083 |
| Word Mark | CKD |
| Filing Date | Tuesday, January 28, 2025 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, March 9, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Testing, inspection or research of pharmaceuticals namely targeted protein degrader for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases; consulting services in the field of testing, inspection or research of pharmaceuticals namely, targeted protein degrader for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases; providing scientific information about medical testing of pharmaceuticals, and providing medical and scientific testing, inspection and research information in the field of pharmaceuticals namely, targeted protein degrader for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases; Medical and scientific research, namely, conducting clinical trials for pharmaceuticals in the field of targeted protein degrader for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases; research and development services in the field of pharmaceutical preparations namely, targeted protein degrader for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases |
| Goods and Services | Custom manufacture of pharmaceuticals namely targeted protein degrader for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases |
| Goods and Services | Pharmaceutical preparations, namely, targeted protein degrader for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases; pharmaceuticals namely targeted protein degrader for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases; medicines for human purposes namely, targeted protein degrader for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases; target protein degrader namely, pharmaceutical preparations for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 27, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 27, 2025 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 27, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Tanabe Pharma Corporation |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 98 - Unknown |
| Address | JP |
| Party Name | Mitsubishi Tanabe Pharma Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Event Date | Event Description |
| Thursday, March 27, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Sunday, March 30, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, March 30, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, July 8, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, July 9, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, July 10, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Sunday, August 17, 2025 | REFUSAL PROCESSED BY MPU |
| Sunday, August 17, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, September 5, 2025 | REFUSAL PROCESSED BY IB |
| Tuesday, February 17, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, February 17, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, February 17, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, March 9, 2026 | NON-FINAL ACTION WRITTEN |
| Monday, March 9, 2026 | NON-FINAL ACTION E-MAILED |
| Monday, March 9, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, March 12, 2026 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Thursday, April 2, 2026 | REFUSAL PROCESSED BY IB |